Omeros reported $-37438000 in Operating Profit for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Acelrx Pharmaceuticals ACRX:US $ -13573000 4.58M
Adma Biologics ADMA:US $ 16.96M 38.45M
Aerie Pharmaceuticals AERI:US $ -18.14M 15.51M
Alnylam Pharmaceuticals ALNY:US $ -191.69M 44.95M
Biomarin Pharmaceutical BMRN:US $ 39.15M 98.18M
Cytokinetics CYTK:US $ -10.87M 69.68M
Dynavax Technologies DVAX:US $ 128.23M 97.46M
Gilead Sciences GILD:US $ 2029M 1832M
Heron Therapeutics HRTX:US $ -49.5M 13.42M
Insmed INSM:US $ -88316000 1.52M
Intercept Pharmaceuticals ICPT:US $ -13.36M 3.09M
Knight Therapeutics Inc GUD:CN C$ 2.89M 2.93M
Macrogenics MGNX:US $ -41808000 24.83M
Mirati Therapeutics MRTX:US $ -177.2M 7.01M
Omeros OMER:US $ -37438000 2.39M
Pacira Pharmaceuticals PCRX:US $ 31.24M 13.84M
Pfizer PFE:US $ 12102M 2229M
Regulus Therapeutics RGLS:US $ -7.18M 0.61M
Rockwell Medical RMTI:US $ -4.48M 2.14M
Sangamo Biosciences SGMO:US $ -45.73M 0.47M
Sarepta Therapeutics SRPT:US $ -211.13M 124.25M
United Therapeutics UTHR:US $ 201.8M 84.5M
Vertex Pharmaceuticals VRTX:US $ 1106.3M 65.4M
Vital Therapies VTL:US $ -20.61M 0.82M
Xoma XOMA:US $ -4767000 2.7M